toosendanin has been researched along with Metastase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, B; Du, X; Huo, J; Wang, B; Xu, R; Yang, T; Zhan, Y; Zhang, D; Zhang, Y; Zhu, M | 1 |
| Chen, XY; Hou, LD; Huang, YX; Liu, H; Wang, G; Zhang, J; Zhang, R; Zhu, JS | 1 |
2 other study(ies) available for toosendanin and Metastase
| Article | Year |
|---|---|
WWOX activation by toosendanin suppresses hepatocellular carcinoma metastasis through JAK2/Stat3 and Wnt/β-catenin signaling.
Topics: Carcinoma, Hepatocellular; Drugs, Chinese Herbal; Humans; Janus Kinase 2; Liver Neoplasms; Neoplasm Metastasis; Signal Transduction; STAT3 Transcription Factor; Tumor Suppressor Proteins; Wnt Signaling Pathway; WW Domain-Containing Oxidoreductase | 2021 |
Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC‑7901 cells partly via miR‑200a‑mediated downregulation of β-catenin pathway.
Topics: Animals; Apoptosis; beta Catenin; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Mice; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Stomach Neoplasms; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2017 |